Internal Medicine, Infectious Disease · Fayetteville, GA
NPI
1518283308
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1265 Highway 54 W, Suite 201
Fayetteville, GA, 30214
Phone (678) 435-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$227K
3,070 services
Medicare patients, 2024
510
Average age 73
Drug cost, 2024
$982K
1,132 prescriptions
Company payments, 2025
$234
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ameera W Siddiqi was code 99233 (hospital e&m - subsequent), 514 times for 281 patients. In total Ameera W Siddiqi billed 3,070 services in 29 codes, and Medicare paid $227K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 514 | 281 | $92.95 | $48K |
| 99232 Hospital E&M - Subsequent | Facility | 456 | 214 | $61.71 | $28K |
| 99223 Hospital E&M - Initial | Facility | 283 | 261 | $134.08 | $38K |
| 99214 Office E&M - Established | Office | 157 | 106 | $95.55 | $15K |
| 99213 Office E&M - Established | Office | 39 | 36 | $70.27 | $2,741 |
| 99222 Hospital E&M - Initial | Facility | 25 | 25 | $102.83 | $2,571 |
| 99204 Office E&M - New | Office | 25 | 25 | $127.22 | $3,181 |
By year: 2022 $125K for 2,494 services; 2023 $168K for 2,682 services; 2024 $227K for 3,070 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ameera W Siddiqi prescribed most often to Medicare patients was Daptomycin, with 193 prescriptions and refills. In total Ameera W Siddiqi wrote 1,132 Medicare prescriptions that cost $982K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 193 | 193 | 39 | $270K |
| Ceftriaxone Ceftriaxone Sodium | 180 | 180 | 44 | $14K |
| Ertapenem Ertapenem Sodium | 89 | 89 | 27 | $43K |
| Cefazolin Sodium Generic | 78 | 78 | 15 | $2,669 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 54 | 54 | Under 11 | $221K |
| Cefepime Hcl Generic | 48 | 48 | 17 | $11K |
| Doxycycline Hyclate Generic | 47 | 58 | 26 | $1,633 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 36 | 36 | Under 11 | $140K |
| Meropenem Generic | 32 | 32 | Under 11 | $6,661 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 30 | 48 | Under 11 | $258 |
| Cefuroxime Cefuroxime Axetil | 27 | 27 | 18 | $759 |
| Ciprofloxacin Hcl Generic | 21 | 21 | 13 | $247 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 19 | 19 | Under 11 | $3,088 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 20 | 13 | $431 |
| Fluconazole Generic | 18 | 21 | Under 11 | $370 |
Brand drugs: 290 claims; generic drugs: 842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ameera W Siddiqi $234 ($234 in general payments such as food, travel and fees) from 4 companies. The largest payer was Merck Sharp & Dohme LLC with $78.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.